Beta Drugs Board Approves Auditor Appointments and Director Re-appointment
Beta Drugs Ltd 路 Outcome 路 03 Sept 2026, 11:26 pm
Beta Drugs Board Approves Auditor Appointments and Director Re-appointment Beta Drugs Ltd.'s board met on 3rd Sep'26, scheduling its AGM for 30th Sep'26 with a book closure period from 24th Sep'26 to 30th Sep'26. Crucial leadership resolutions include the re-appointment of Mr. Ashutosh Shukla as Whole-Time Director for a five-year term starting 20th Jan'27, alongside revised remuneration. Additionally, the board re-appointed Khurana Sharma and Co. as Statutory Auditors for two years (FY27-FY28) and named Charu Jindal & Co. and V.K. Srivastava & Associates as Cost and Internal Auditors, respectively, for FY27.
Original exchange filing (PDF)
More announcements from Beta Drugs Ltd
- BETA DRUGS LIMITED has informed the Exchange about Board Meeting to be held on 19-Nov-2026 to consider Other business. 路 16 Nov 2026
- To consider other business matters 路 16 Nov 2026
- Monitoring Agency Report as on 30th September, 2026 路 12 Nov 2026
- Beta Drugs Limited has informed the Exchange about Transcript 路 28 Oct 2026
- Beta Drugs Limited has informed the Exchange about Link of Recording 路 22 Oct 2026
- Beta Drugs Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 路 22 Oct 2026
- Beta Drugs Limited has informed the Exchange about Presentation 路 22 Oct 2026
- Beta Drugs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 22 Oct 2026
